PDRX Financials
Pd-Rx Pharmaceutical - Financial statements & key metrics
Stock Price
$3.35
Market Cap
$5.75M
P/E Ratio
3.1
EPS
$1.08
Income Statement Highlights
Most Recent Quarter: 2025-06-30
Revenue
$18.35M
Gross Profit
-
Operating Income
$-477417.00
Net Income
$-257523.00
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$11.98M
Total Liabilities
$1.74M
Shareholders Equity
$10.24M
Cash & Equivalents
$6.17M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$765032.00
CapEx
$2442
Free Cash Flow
$762,590
Profitability Metrics
Gross Margin
29.6%
Operating Margin
0.0%
Net Margin
-0.0%
ROE
-0.0%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is PDRX revenue?
PDRX's most recent quarterly revenue was $18.35M. Annual revenue can be calculated by summing the four most recent quarters.
Is PDRX profitable?
PDRX reported a loss of $257,523 in the most recent quarter. The net profit margin is -0.0%.
What is PDRX market cap?
PDRX has a market capitalization of $5.75M, making it a small-cap stock.
Does PDRX have debt?
View PDRX's balance sheet for debt information.
What is PDRX cash flow?
PDRX's most recent quarterly free cash flow was $762,590.